Filing Flows › Enanta Pharmaceuticals (ENTA) › How it makes money
How Enanta Pharmaceuticals (ENTA) makes money
Enanta Pharmaceuticals (ENTA) made $14.4M of revenue in the third quarter fiscal 2026 (Q3 FY26), -22% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 FY26 | % of revenue |
|---|---|---|
| Revenue | $14.4M | 100.0% |
| Income tax | $36K | 0.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 FY26 | $14.4M | -22% |
| Q2 FY26 | $17.2M | +15% |
| Q1 FY26 | $18.6M | +10% |
| Q4 FY25 | $15.1M | +4% |
| Q3 FY25 | $18.3M | +2% |
| Q2 FY25 | $14.9M | -12% |
| Q4 FY24 | $14.6M | -23% |
From Enanta Pharmaceuticals' 10-Q filed Aug 12, 2026 (on EDGAR).
Questions
How does Enanta Pharmaceuticals make money?
Enanta Pharmaceuticals (ENTA) made $14.4M of revenue in the third quarter fiscal 2026 (Q3 FY26), -22% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.